New TrialSpark Antibody Study

September 14, 2020

Dr. Michael Mina of the Harvard School of Public Health has partnered with TrialSpark to bring a novel coronavirus research study to COVID-19 Symptom Study participants in select zipcodes in Massachusetts. If you live or work in the area, have Internet access and complete an application, and are willing to provide samples for testing, you may be eligible for the study. 

The study will allow participants to take an at-home antibody test to discover whether they have been exposed to the virus in the past. The results will not be shared with anyone except for the participant and study investigators. This a promising additional study for those based in Massachusetts, and we hope it will help us to gauge the spread of the disease in the area.

Text Link

Other updates

Close

Get in touch

Please complete the reCAPTCHA and try again

Thank you

Your submission has been received
Oops! Something went wrong while submitting the form.